Posts for the 'Fosamax' Category
Fosamax jawbone danger not disclosed in current ads
In this morning’s Washington Post, a letter to the editor criticized the advertisement of Fosamax on television given the risk of jawbone infections. Ronald S. Brown, a professor of oral diagnosis at the Howard University College of Dentistry, stated: Read the rest of this entry »
Occurrence of Fosamax jaw bone decay is likely to increase
Although Fosamax was approved by the FDA in 1995, the first reports of jaw bone decay side effects did not surface until early 2005. The reason for this long delay is that the risk of jaw bone deterioration increases with long term use of the medication. Read the rest of this entry »
